Ovid Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 11, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	208	66	228	131	219	147
Market Cap Growth	299.32%	-70.87%	73.64%	-40.03%	49.16%	-26.16%
Enterprise Value	191	19	157	9	17	60
Last Close Price	1.64	0.93	3.22	1.86	3.21	2.31
PE Ratio	-	-	-	-	1.82	-
PS Ratio	17.63	117.14	580.59	87.22	1.05	11.61
PB Ratio	2.61	0.97	2.59	0.99	1.22	3.36
P/TBV Ratio	4.54	0.97	2.60	0.99	1.22	3.38
P/FCF Ratio	-	-	-	-	1.85	-
P/OCF Ratio	-	-	-	-	1.84	-
EV/Sales Ratio	28.93	32.98	400.05	6.30	0.08	4.73
EV/EBITDA Ratio	-	-	-	-	0.14	-
EV/EBIT Ratio	-	-	-	-	0.14	-
EV/FCF Ratio	-	-	-	-	0.14	-
Debt / Equity Ratio	0.31	0.22	0.18	0.13	-	-
Asset Turnover	0.08	0.01	0.00	0.01	1.54	0.16
Quick Ratio	3.77	5.04	9.23	18.45	12.69	3.27
Current Ratio	4.24	5.32	9.55	18.79	12.87	3.39
Return on Equity (ROE)	-60.06%	-33.88%	-47.57%	-34.72%	109.98%	-142.60%
Return on Assets (ROA)	-29.33%	-30.90%	-24.05%	-19.85%	57.40%	-64.93%
Return on Invested Capital (ROIC)	-121.33%	-418.97%	-648.00%	-392.69%	-	-
Return on Capital Employed (ROCE)	-68.50%	-71.50%	-43.40%	-37.50%	69.10%	-151.20%
Earnings Yield	-17.66%	-39.87%	-23.00%	-41.33%	56.20%	-55.30%
FCF Yield	-18.69%	-84.50%	-20.13%	-43.07%	54.18%	-35.29%
Buyback Yield / Dilution	-0.35%	-0.46%	-0.22%	-3.46%	-16.45%	-49.05%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q